---
figid: PMC5974248__fimmu-09-01017-g003
figlink: /pmc/articles/PMC5974248/figure/F3/
number: F3
caption: 'Involvement of optineurin in nuclear factor kappa B (NF-κB) signaling. Upon
  Toll-like receptor (TLR) signaling the NF-κB pathway is activated, leading to expression
  of inflammatory cytokines. This is mediated via interleukin-1 receptor-associated
  kinases (IRAKs) and TRAF. NEMO binds to the I kappa B (IKB) complex, leading to
  its phosphorylation and consequent degradation, and translocation of p50/p65 to
  the nucleus. NEMO also interacts with receptor-interacting protein (RIP) and trans-activating
  transcriptional regulatory protein of HTLV-1 (TAX1). Overexpression of wild-type
  or ALS mutant optineurin blocks NF-κB activation. Depletion of optineurin or overexpression
  of the glaucoma mutants leads to failure to inhibit NF-κB, leading to activation
  of this pathway. Optineurin binds to TAX1, blocking its interaction with NEMO and
  further inhibiting the pathway. Interferon regulatory factors are activated during
  TLR activation. IRF3 and IRF7 activation is mediated by TBK-1, and TBK-1 undergoes
  phosphorylation and ubiquitination during its activation. Optineurin binds to TBK-1,
  targeting it to CYLD, which inhibits its enzymatic activity. Abbreviations: OPTN−:
  optineurin depletion, OPTN+: optineurin overexpression, OPTN ALS: ALS mutant optineurin,
  OPTN Glaucoma: glaucoma mutant optineurin.'
pmcid: PMC5974248
papertitle: Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma.
reftext: Reka P. Toth, et al. Front Immunol. 2018;9:1017.
pmc_ranked_result_index: '12924'
pathway_score: 0.9005892
filename: fimmu-09-01017-g003.jpg
figtitle: Involvement of optineurin in nuclear factor kappa B (NFKB) signaling
year: '2018'
organisms: Homo sapiens
ndex: 15d9e1ee-df11-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5974248__fimmu-09-01017-g003.html
  '@type': Dataset
  description: 'Involvement of optineurin in nuclear factor kappa B (NF-κB) signaling.
    Upon Toll-like receptor (TLR) signaling the NF-κB pathway is activated, leading
    to expression of inflammatory cytokines. This is mediated via interleukin-1 receptor-associated
    kinases (IRAKs) and TRAF. NEMO binds to the I kappa B (IKB) complex, leading to
    its phosphorylation and consequent degradation, and translocation of p50/p65 to
    the nucleus. NEMO also interacts with receptor-interacting protein (RIP) and trans-activating
    transcriptional regulatory protein of HTLV-1 (TAX1). Overexpression of wild-type
    or ALS mutant optineurin blocks NF-κB activation. Depletion of optineurin or overexpression
    of the glaucoma mutants leads to failure to inhibit NF-κB, leading to activation
    of this pathway. Optineurin binds to TAX1, blocking its interaction with NEMO
    and further inhibiting the pathway. Interferon regulatory factors are activated
    during TLR activation. IRF3 and IRF7 activation is mediated by TBK-1, and TBK-1
    undergoes phosphorylation and ubiquitination during its activation. Optineurin
    binds to TBK-1, targeting it to CYLD, which inhibits its enzymatic activity. Abbreviations:
    OPTN−: optineurin depletion, OPTN+: optineurin overexpression, OPTN ALS: ALS mutant
    optineurin, OPTN Glaucoma: glaucoma mutant optineurin.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGFALS
  - TLR2
  - TLR4
  - TLR1
  - TLR5
  - TLR10
  - TLR3
  - MYD88
  - TLR6
  - TLR7
  - TRAF6
  - TBK1
  - IKBKB
  - IKBKE
  - TLR8
  - TLR9
  - IRF3
  - IRF7
  - IRAK1
  - IRAK4
  - CNTN2
  - IKBKG
  - CHUK
  - OPTN
  - Glaucoma
genes:
- word: ALS
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: TBK-1
  symbol: TBK1
  source: hgnc_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: IKK-B
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKK-E
  symbol: IKKE
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKE
  entrez: '9641'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: IRF7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: IRAK1
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: IRAK4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: TAX1
  symbol: TAX1
  source: hgnc_alias_symbol
  hgnc_symbol: CNTN2
  entrez: '6900'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IKK-a
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: OPTN
  symbol: OPTN
  source: hgnc_symbol
  hgnc_symbol: OPTN
  entrez: '10133'
chemicals: []
diseases:
- word: Glaucoma
  source: MESH
  identifier: D005901
figid_alias: PMC5974248__F3
redirect_from: /figures/PMC5974248__F3
figtype: Figure
---
